Related Experiment Videos
Second HLA-A*68 null allele, A*6818 N, identified
A Dormoy1, N Froelich, A Parissiadis
1Etablissment Fançais du Sang-Alsace, Starsbourg, France. anne.dormoy@etss.u-strasbg.fr
Tissue Antigens
|October 9, 2002
Summary
A novel human leukocyte antigen (HLA)-A*68 null allele, HLA-A*6818 N, was discovered due to typing discrepancies in a narcolepsy patient. This allele contains a duplicated sequence causing a premature stop codon, impacting HLA-A expression.
Area of Science:
- Immunogenetics
- Molecular Biology
- Human Leukocyte Antigen (HLA) System
Background:
- Accurate human leukocyte antigen (HLA) typing is crucial for transplantation and disease association studies.
- Discrepancies in HLA typing can indicate novel allele discovery or technical issues.
Observation:
- A male narcolepsy patient exhibited conflicting results between serological and molecular HLA class I typing.
- Sequence analysis revealed a novel HLA-A*68 null allele, designated HLA-A*6818 N.
Findings:
- The HLA-A*6818 N allele shares sequence identity with HLA-A*6802 but contains a 20-nucleotide duplication in exon 2.
- This duplication causes a frameshift mutation, resulting in a premature stop codon at position 59.
Implications:
- Discovery of HLA-A*6818 N expands the known HLA-A allele repertoire.
- This finding may have implications for understanding HLA associations with narcolepsy and other immune-related disorders.
- Null alleles can affect immune responses and require careful consideration in HLA typing and research.